MESO250117C00000500 Option on Mesoblast

MESO Stock  USD 17.90  1.06  5.59%   
MESO250117C00000500 is a PUT option contract on Mesoblast's common stock with a strick price of 0.5 expiring on 2025-01-17. The contract was not traded in recent days and, as of today, has 9 days remaining before the expiration. The option is currently trading at a bid price of $0.05, and an ask price of $5.0. The implied volatility as of the 8th of January is 9.0.
  
A put option written on Mesoblast becomes more valuable as the price of Mesoblast drops. Conversely, Mesoblast's put option loses its value as Mesoblast Stock rises.

Rule 16 of 2025-01-17 Option Contract

The options market is anticipating that Mesoblast will have an average daily up or down price movement of about 0.0% per day over the life of the option. With Mesoblast trading at USD 17.9, that is roughly USD 0.0. If you think that the market is fully understating Mesoblast's daily price movement you should consider buying Mesoblast options at that current volatility level of 0.0%. But if you have an opposite viewpoint you should avoid it and even consider selling them.

Out Of The Money Call Option on Mesoblast

An 'Out of The Money' option on Mesoblast has a strike price that Mesoblast Stock has yet to reach, meaning the option has no intrinsic value. 'Out of The Money' options are usually less costly than 'In The Money' options, making them more desirable to traders with smaller amounts of capital. Some of the uses for Mesoblast's 'Out of The Money' options include buying the options if you expect a big move in Mesoblast's stock. Since 'Out of The Money' options have a lower up-front cost (i.e., no intrinsic value) than 'In The Money' options, buying it is a reasonable choice.
Call Contract NameMESO250117C00000500
Expires On2025-01-17
Days Before Expriration9
Open Interest58
Strike Price0.5
Current Price Spread0.05 | 5.0

Mesoblast long PUT Option Payoff at expiration

Put options written on Mesoblast grant holders of the option the right to sell a specified amount of Mesoblast at a specified price within a specified time frame. The put buyer has a limited loss and, while not fully unlimited gains, as the price of Mesoblast Stock cannot fall below zero, the put buyer does gain as the price drops. So, purchasing a put option on Mesoblast is like buying insurance aginst Mesoblast's downside shift.
   Profit   
       Mesoblast Price At Expiration  

Mesoblast short PUT Option Payoff at expiration

By selling Mesoblast's put option, the investors signal their bearish sentiment. A short position in a put option written on Mesoblast will generally make money when the underlying price is above the strike price. Therefore Mesoblast's put payoff at expiration depends on where the Mesoblast Stock price is relative to the put option strike price. The breakeven price of 0.5 is the critical point that divides the payoff function into two parts. Below the breakeven price, the payoff is dropping and negative (the seller makes a loss). Above the breakeven price, the payoff line is upward sloping as the option payoff increases in proportion to Mesoblast's price. Finally, at the strike price of 0.5, the payoff chart is constant and positive.
   Profit   
       Mesoblast Price At Expiration  
View All Mesoblast Options

Mesoblast Available Call Options

Mesoblast's option chain is a display of a range of information that helps investors for ways to trade options on Mesoblast. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Mesoblast. It also shows strike prices and maturity days for a Mesoblast against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
Call
MESO250117C00000500580.50.05 - 5.00.05Out
Call
MESO250117C000010001851.00.1 - 0.80.1Out
Call
MESO1250117C0000050000.50.4 - 0.850.4Out
Call
MESO250117C0000150041.50.2 - 0.80.2Out
Call
MESO250117C0000200002.00.15 - 0.650.15Out
Call
MESO250117C000025008012.50.3 - 0.60.3Out
Call
MESO250117C0000300003.00.1 - 0.50.1Out
Call
MESO250117C0000400004.00.05 - 0.450.05Out
Call
MESO250117C0000500015505.00.0 - 0.50.5Out
Call
MESO250117C000075009197.50.1 - 0.250.1Out

Mesoblast Corporate Management

LLB BComJoint SecretaryProfile
Justin BSHead ManufacturingProfile
Marcelo SantoroChief OfficerProfile
Roger BAHead DisordersProfile
Fiona SeeSenior ResearchProfile
MS MBAChief OfficerProfile
BSc LLBGen ExecProfile
When determining whether Mesoblast offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Mesoblast's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mesoblast Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mesoblast Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mesoblast. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
To learn how to invest in Mesoblast Stock, please use our How to Invest in Mesoblast guide.
You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mesoblast. If investors know Mesoblast will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mesoblast listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.05)
Revenue Per Share
0.06
Quarterly Revenue Growth
(0.41)
Return On Assets
(0.05)
Return On Equity
(0.18)
The market value of Mesoblast is measured differently than its book value, which is the value of Mesoblast that is recorded on the company's balance sheet. Investors also form their own opinion of Mesoblast's value that differs from its market value or its book value, called intrinsic value, which is Mesoblast's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mesoblast's market value can be influenced by many factors that don't directly affect Mesoblast's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mesoblast's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mesoblast is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mesoblast's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.